AMGN

Amgen Inc. News Headlines

$139.38
*  
0.69
0.5%
Get AMGN Alerts
*Delayed - data as of Aug. 29, 2014 13:50 ET  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Today's Market: Red Hot Biotech And Big Pharma Names To Watch
8/29/2014 8:22:00 AM - Seeking Alpha

Amgen's Chronic Heart Failure Drug Gets Priority Review - Analyst Blog
8/28/2014 6:20:00 PM - Zacks.com

Aegerion Resolves FDA's Warning on Juxtapid, Lifts Overhang - Analyst Blog
8/28/2014 5:50:00 PM - Zacks.com

MediciNova Rises on FDA's Nod on MN-166 Study Initiation - Analyst Blog
8/28/2014 5:00:00 PM - Zacks.com

BioTime's AST-OPC1 Cleared by FDA for Phase I/IIa Study - Analyst Blog
8/28/2014 4:35:00 PM - Zacks.com

Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog
8/28/2014 4:30:00 PM - Zacks.com

Nasdaq 100 Movers: VIP, VRTX
8/28/2014 12:19:39 PM - BNK Invest

Amgen Submits BLA For Evolocumab - Quick Facts
8/28/2014 9:17:00 AM - RTT News

Amgen Gets FDA Priority Review For Heart Drug - Update
8/27/2014 2:12:00 PM - RTT News

VUG, FB, AMGN, AXP: ETF Inflow Alert
8/27/2014 10:52:17 AM - BNK Invest

Why Amgen (AMGN) Stock Hit a One-Year High Today
8/27/2014 10:32:00 AM - TheStreet

Return To Behemoth Stocks
8/27/2014 10:25:00 AM - Seeking Alpha

Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog
8/27/2014 9:49:00 AM - Zacks.com

Why Amgen Stock Is A Long-Term Investment Opportunity
8/27/2014 9:48:00 AM - Seeking Alpha

7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
8/26/2014 9:56:04 PM - Motley Fool

Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog
8/26/2014 6:44:00 PM - Zacks.com

HCP Boasts Of 29 Years Of Dividend Increases
8/26/2014 5:27:00 PM - Investor's Business Daily

Regado Slumps on Permanent Termination of Revolixys Study - Analyst Blog
8/26/2014 5:20:00 PM - Zacks.com

VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog
8/26/2014 5:00:00 PM - Zacks.com

Why I Bought Into Monday's Move In Regeneron
8/26/2014 11:16:00 AM - Seeking Alpha

3 Reasons Amgen Inc.'s Stock Could Fall
8/26/2014 9:43:39 AM - Motley Fool

3 Reasons Celgene Corporation's Stock Could Fall
8/26/2014 8:49:24 AM - Motley Fool

Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
8/25/2014 6:25:00 PM - Zacks.com

Western Digital Says Tim Leyden To Retire As CFO - Quick Facts
8/25/2014 4:41:00 PM - RTT News

Zacks Rank #1 Additions for Monday - Tale of the Tape
8/25/2014 9:30:00 AM - Zacks.com